Lloyd Mitchell Segal - 21 Jan 2022 Form 4/A - Amendment Insider Report for Repare Therapeutics Inc. (RPTX)

Role
President and CEO, Director
Signature
/s/ Steve Forte, Attorney-in-Fact
Issuer symbol
RPTX
Transactions as of
21 Jan 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
24 Jan 2022, 15:55:15 UTC
Date Of Original Report
20 Jan 2022
Previous filing
20 Jan 2022
Next filing
01 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RPTX Employee Stock Option (right to buy) Options Exercise $0 +300,000 $0.000000 300,000 21 Jan 2022 Common Shares 300,000 $15.63 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 amendment is being filed to correct the original Form 4 filed on January 20, 2022. The original Form 4 was filed early with an incorrect Transaction Date due to a clerical error.
F2 Twenty-five percent (25%) of the shares subject to the option shall vest on January 18, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.